1 – 2 of 2
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup
(
- Contribution to journal › Article
- 2015
-
Mark
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
(
- Contribution to journal › Article